【水腫】《Intellia:NTLA》公布「遺傳性血管性水腫(HAE)」CRISPR基因治療臨床一期結果

 【水腫】《Intellia:NTLA》公布「遺傳性血管性水腫(HAE)」CRISPR基因治療臨床一期結果

▌文章出處

 GlobeNewswire

▌原文標題

 Intellia Therapeutics Announces New Positive Clinical Data from Phase 1 Study of NTLA-2002, an Investigational In Vivo CRISPR Genome Editing Treatment for Hereditary Angioedema (HAE)

▌Twitter

 https://twitter.com/aimedadviser/status/1668410431160094722

▌文章序號

 3679

｜智醫科學－AI醫療技術、應用與市場動態

Copyright ©2023 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.